Adverse reaction reporting of interaction between warfarin and fluoroquinolones

Area of Science:

• Pharmacology
• Drug Interactions
• Clinical Medicine

Background:

• Warfarin sodium is a widely used anticoagulant.
• Fluoroquinolones are broad-spectrum antibiotics.
• Potential drug interactions require careful consideration for patient safety.

Purpose of the Study:

• To investigate suspected interactions between warfarin sodium and fluoroquinolones.
• To analyze adverse event reports of prolonged prothrombin time.
• To identify potential mechanisms for this drug interaction.

Main Methods:

• Review of adverse event reports submitted to the Food and Drug Administration's Adverse Drug Reaction Reporting System.
• Analysis of five case reports detailing prolonged prothrombin time.
• Examination of potential pharmacological mechanisms.

Main Results:

• Five reports indicated prolonged prothrombin time after initiating fluoroquinolone therapy in patients on warfarin.
• The adverse reaction occurred within 2 to 16 days of adding the fluoroquinolone.
• Potential mechanisms include inhibited warfarin metabolism and protein binding displacement.

Conclusions:

• A potential interaction exists between warfarin sodium and fluoroquinolones, leading to increased prothrombin time.
• Physicians should be vigilant for this interaction.
• Close monitoring of prothrombin time is crucial for patients on concurrent warfarin and fluoroquinolone therapy.